VIRDANTE PHARMACEUTICALS, INC.

Profile

Company Names

VIRDANTE PHARMACEUTICALS, INC.

Addresses

101 MAIN STREET, SUITE 1210, CAMBRIDGE, MA 02142

Phone Numbers

617-300-8500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$30,075,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2008-01-30 
$30,075,000.00 
$47,750,000.00 
$17,675,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ERIC 
 
AGUIAR 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  LOCUS DEVELOPMENT INC   |  INVITAE CORP   |  EIDOS THERAPEUTICS, INC.   |  GARUDA THERAPEUTICS, INC.
L. 
PATRICK 
GAGE 
DIRECTOR
ALVINE PHARMACEUTICALS INC   |  VIRDANTE PHARMACEUTICALS, INC.   |  TETRAPHASE PHARMACEUTICALS INC
ANDERS 
 
HOVE 
DIRECTOR
QUATRX PHARMACEUTICALS CO   |  ALIMERA SCIENCES INC   |  VIRDANTE PHARMACEUTICALS, INC.   |  ANACOR PHARMACEUTICALS INC   |  STILL RIVER SYSTEMS INC   |  MEVION MEDICAL SYSTEMS, INC.   |  ANACOR PHARMACEUTICALS, INC.
JOHN 
 
RIPPLE 
EXECUTIVE OFFICER, DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  EXONICS THERAPEUTICS, INC.   |  LUCY THERAPEUTICS, INC.   |  PRAESIDIA BIOTHERAPEUTICS, INC.
MICHAEL 
 
STEINMETZ 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  MACROGENICS INC   |  ALLOZYNE INC   |  VARIATION BIOTECHNOLOGIES (US), INC.   |  LYCERA CORP   |  VBI VACCINES INC.
GAIL 
 
WASSERMAN 
DIRECTOR
VIRDANTE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-10-14
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-30 
2010-10-21
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-30 
2009-10-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-01-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#